Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Issue Section
Date
Availability
1-20 of 29
Keywords: Urinary tract infection
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
1
Sort by
Journal Articles
Journal:
Chemotherapy
Chemotherapy (2022) 67 (4): 261–268.
Published Online: 02 May 2022
...Haedi Thelen; Thomas J. Dilworth; Renée-Claude Mercier Introduction: Community-acquired urinary tract infections (UTIs) caused by extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli have limited oral therapeutic options and pose significant clinical challenges. The goal of this study...
Journal Articles
Stephanie E. Giancola, Monica V. Mahoney, Michael D. Hogan, Brian R. Raux, Christopher McCoy, Elizabeth B. Hirsch
Journal:
Chemotherapy
Chemotherapy (2017) 62 (2): 100–104.
Published Online: 28 October 2016
... for uncomplicated urinary tract infections (UTIs) and displays in vitro activity against multidrug-resistant (MDR) isolates; however, clinical data assessing fosfomycin for the treatment of complicated or MDR UTIs are limited. Methods: We conducted a retrospective evaluation of patients who received ≥1 dose...
Journal Articles
Adriano M. Ferreira, Mariana F. Bonesso, Alessandro L. Mondelli, Carlos H. Camargo, Maria de Lourdes R.S. Cunha
Journal:
Chemotherapy
Chemotherapy (2013) 58 (6): 482–491.
Published Online: 16 April 2013
...Adriano M. Ferreira; Mariana F. Bonesso; Alessandro L. Mondelli; Carlos H. Camargo; Maria de Lourdes R.S. Cunha Background: Staphylococcus saprophyticus is the second most frequent community-acquired causative agent of urinary tract infection (UTI). The objective of this study was to evaluate...
Journal Articles
Journal:
Chemotherapy
Chemotherapy (1996) 42 (Suppl. 1): 17–27.
Published Online: 11 September 2009
...Helen Giamarellou The clinical evaluation of antimicrobial agents for the treatment of urinary tract infections (UTIs) requires clinically useful categorization of patients plus concurrent laboratory diagnosis. Appropriate diagnostics include (1) proper collection techniques, (2) quantitative urine...
Journal Articles
Journal:
Chemotherapy
Chemotherapy (1996) 42 (Suppl. 1): 10–16.
Published Online: 11 September 2009
...Ross R. Bailey A single oral dose of an antimicrobial agent is as effective as a conventional 3-day course for the treatment of uncomplicated lower urinary tract infections. A case history of a young woman with recurrent cystitis is presented to demonstrate this approach to the management...
Journal Articles
Journal:
Chemotherapy
Chemotherapy (1994) 40 (6): 435–440.
Published Online: 11 September 2009
... of a prospective study with 170 renal transplant patients, undertaken to evaluate the efficacy of ceftriaxone in the prevention of wound and early urinary tract infection. No wound infection was observed, however, 12 patients (7.1%) developed urinary tract infections. On the basis of these data, we recommend...
Journal Articles
Journal:
Chemotherapy
Chemotherapy (1997) 43 (6): 424–429.
Published Online: 11 September 2009
... especially in urinary tract infections with Proteus strains. 11 9 2009 © 1997 S. Karger AG, Basel 1997 Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means...
Journal Articles
Misao Sakumoto, Tetsuro Matsumoto, Osamu Mochida, Yoshimitsu Mizunoe, Joichi Kumazawa, Ariaki Nagayama
Journal:
Chemotherapy
Chemotherapy (1996) 42 (5): 329–333.
Published Online: 11 September 2009
... Staphylococcus aureus (MRSA), methicillin-sensitive Staphylococcus aureus (MSSA) and Staphylococcus epidermidis isolated from patients with complicated urinary tract infections (UTIs). All the strains of MRSA and MSSA showed a low sensitivity to imipenem (IPM), ceftazidime (CAZ), fiomoxef (FMOX), amikacin (AMK...
Journal Articles
Journal:
Chemotherapy
Chemotherapy (1986) 32 (1): 83–87.
Published Online: 09 September 2009
...H. Van Poppel; M. Wegge; H. Dammekens; V. Chysky In an open study, a group of 11 patients with asymptomatic urinary tract infections, caused by resistant Pseudomonas strains, were given 200 mg of ciprofloxacin per day for 1 week. All strains displayed an in vitro sensitivity to the drug. Complete...
Journal Articles
Journal:
Chemotherapy
Chemotherapy (1990) 36 (Suppl. 1): 41–45.
Published Online: 09 September 2009
... to indicate that this antibiotic may be used in single doses in the therapy of lower urinary tract infections (UTIs) in infants and children. The efficacy and safety of FT in single oral doses was compared with those of netilmicin (NM), an aminoglycoside antibiotic with a demonstrated efficacy in bolus doses...
Journal Articles
Journal:
Chemotherapy
Chemotherapy (1990) 36 (Suppl. 1): 46–49.
Published Online: 09 September 2009
...G. Ferraro; G. Ambrosi; L. Bucci; R. Palmieri; G. Palmieri Ten years of controlled clinical trials supported single-dose therapy efficacy and safety in uncomplicated lower urinary tract infections (UTI). Both local and systematic factors contribute to the high UTI prevalence seen in elderly people...
Journal Articles
Fosfomycin Trometamol versus Amoxycillin – Single-Dose Multicenter Study of Urinary Tract Infections
Journal:
Chemotherapy
Chemotherapy (1990) 36 (Suppl. 1): 19–23.
Published Online: 09 September 2009
... agents. The most common failure was with E. coli for both agents. Side effects were minimal with 8.7% for fosfomycin trometamol and 11.5% for amoxycillin. Fosfomycin trometamol is effective therapy of acute urinary tract infections in adult females and in selected situations was superior to amoxycillin...
Journal Articles
Journal:
Chemotherapy
Chemotherapy (1989) 35 (Suppl. 1): 101–105.
Published Online: 09 September 2009
...A. Constantopoulos; L. Thomaidou; H. Loupa; G. Papoulias Aztreonam was administered to 25 neonates (16 term, 9 premature) with clinically and bacteriologically proved gram-negative infections. Ten patients had meningitis, 9 had septicemia and 6 had urinary tract infections. Patients were between 1...
Journal Articles
Journal:
Chemotherapy
Chemotherapy (1989) 35 (Suppl. 1): 31–38.
Published Online: 09 September 2009
...J. Feris; N. Moledina; W.J. Rodriguez; W.N. Khan; J.P. Puig; B.L. Wiedermann; S. Ahmad Ninety patients (41 males, 49 females) with a diagnosis of meningitis, urinary tract infection (UTI), gastroenteritis or other miscellaneous gram-negative infections were enrolled. Their ages ranged from 7 days...
Journal Articles
Journal:
Chemotherapy
Chemotherapy (1989) 35 (Suppl. 1): 45–48.
Published Online: 09 September 2009
.... The current study was undertaken to determine the efficacy of aztreonam in treating gram-negative infections caused by multiresistant microorganisms in patients with known sensitivity to penicillins and cephalosporins. Sixty-six patients presented with urinary tract infection (UTI) and 30 with respiratory...
Journal Articles
Journal:
Chemotherapy
Chemotherapy (1986) 32 (3): 299–304.
Published Online: 09 September 2009
...Tatsuo Doi; Tsuneo Nishiura; Koichi Deguchi; Masahiro Kondo The clinical efficacy of the combination therapy with cefmenoxime plus cefsulodin was studied in patients with complicated urinary tract infections caused by Pseudomonas aeruginosa . Patients received 1 g of CMX and 1 g of CFS...
Journal Articles
Journal:
Chemotherapy
Chemotherapy (1985) 31 (6): 476–479.
Published Online: 09 September 2009
...Richard Jaffe; Marco Altaras; Moshe Fejgin; Noah Ben-Aderet The efficacy of a preoperative single-dose of co-trimoxazole in reducing postoperative urinary tract infection and febrile morbidity after abdominal hysterectomy was evaluated in a randomized placebo-controlled study of 90 patients...
Journal Articles
Journal:
Chemotherapy
Chemotherapy (1982) 28 (1): 64–69.
Published Online: 08 September 2009
...F. Paradisi; P. Cristiano; V. Mirone; V. D’Armiento; M.R. Iovene A total of 30 hospitalized patients with upper and lower urinary tract infections were treated with cefotaxime (HR-756) by intramuscular or intravenous route. All patients had a monomicrobial infection, and the major part of bacterial...
Journal Articles
Journal:
Chemotherapy
Chemotherapy (1978) 24 (4): 249–258.
Published Online: 08 September 2009
... or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Escherichia coli Nalidixic acid Bacterial resistance Urinary tract infection...
Journal Articles
Journal:
Chemotherapy
Chemotherapy (1977) 23 (5): 337–344.
Published Online: 05 August 2009
...Jouko Tuomisto; Antero Kasanen; Olli-Veikko Renkonen In a clinical double-blind study on 198 patients with a urinary tract infection, no differences were found between comparable groups treated with either sulfadiazine (SD) 1,000 mg/trimethoprim (TM) 320 mg or sulfamethoxazole (SM) 1,600 mg...
1